Publicaciones en las que colabora con Javier Arbizu Lostao (35)

2024

  1. Agrypnia Excitata and Supranuclear Vertical Gaze Palsy Linked to Anti-Ma Encephalitis

    Movement Disorders Clinical Practice, Vol. 11, Núm. 5, pp. 571-574

2022

  1. Update on the diagnosis of encephalitis

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 4, pp. 247-257

2021

  1. [18F]-FDG PET imaging in autoimmune GFAP meningoencephalomyelitis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 3, pp. 947-948

2020

  1. 18F-FDG-PET Imaging Patterns in Autoimmune Encephalitis: Impact of Image Analysis on the Results

    Diagnostics, Vol. 10, Núm. 6

  2. Caspr2 antibody-associated limbic encephalitis: contribution of visual aided analysis of 18F-FDG PET images using normal database comparison

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 2, pp. 92-95

  3. Current role of 18F-FDG-PET in the differential diagnosis of the main forms of dementia

    Clinical and Translational Imaging, Vol. 8, Núm. 3, pp. 127-140

  4. Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS-PSP Criteria

    Movement Disorders, Vol. 35, Núm. 11, pp. 2009-2018

2019

  1. Erratum: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience (PLoS ONE (2019)14:6 (e0217881)Doi:10.1371/journal.pone.0217881)

    PLoS ONE

  2. Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience

    PLoS ONE, Vol. 14, Núm. 6

  3. Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)

    NeuroImage: Clinical, Vol. 23

2018

  1. Early- and late-onset Alzheimer disease: Are they the same entity?

    Neurologia

2017

  1. Emerging clinical issues and multivariate analyses in PET investigations

    Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 61, Núm. 4, pp. 386-404

2015

  1. Descripción de una serie de pacientes con diagnóstico de enfermedad priónica

    Neurologia, Vol. 30, Núm. 3, pp. 144-152

  2. Metabolic patterns in prion diseases: an FDG PET voxel-based analysis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 42, Núm. 10, pp. 1522-1529

  3. Monitoring the Effect of Immunotherapy in Autoimmune Limbic Encephalitis Using 18F-FDG PET

    Clinical nuclear medicine, Vol. 40, Núm. 9, pp. e441-e443

2014

  1. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: A two-step process

    Brain, Vol. 137, Núm. 8, pp. 2356-2367

  2. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway

    Neurobiology of Disease, Vol. 62, pp. 250-259

  3. Neuroimagen funcional en el diagnóstico de pacientes con síndrome parkinsoniano: Actualización y recomendaciones para el uso clínico

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 33, Núm. 4, pp. 215-226

2013

  1. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Núm. 9, pp. 1394-1405

  2. Neuroimagen estructural y funcional en las enfermedades priónicas humanas

    Neurologia